The R6 lines of transgenic mice: A model for screening new therapies for Huntington's disease
Joana Gil‐Mohapel(University of Victoria), A. Cristina Rego(University of Coimbra)
Cited by 63
Related Papers
Dysfunctional synapse in Alzheimer's disease – A focus on NMDA receptors
|Neuropharmacology|2013|201
Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington’s disease knock-in striatal cells
|Free Radical Biology and Medicine|2014|138
Hippocampal Neurogenesis Levels Predict WATERMAZE Search Strategies in the Aging Brain
|PLoS ONE|2013|120
Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease
|Journal of Neuroscience|2017|62
Uncovering the Early Events Associated with Oligomeric Aβ-Induced Src Activation
|Antioxidants|2023|4